Top Biotechnology companies in Europe by Free Cash Flow

This ranking features the top 260 Biotechnology companies in Europe ranked by Free Cash Flow, totaling a Free Cash Flow of USD 71.22 B, for July 03, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Europe has the highest Free Cash Flow ?

The Biotechnology company in Europe with the highest Free Cash Flow is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 16.61 B.

Which Biotechnology company in Europe has the lowest Free Cash Flow ?

The Biotechnology company in Europe with the lowest Free Cash Flow is Clinical Laserthermia Systems AB (publ) (Stockholm Stock Exchange: CLS-B.ST) at None.

What are the top 10 Biotechnology companies in Europe by Free Cash Flow ?

The top 10 Biotechnology companies in Europe by Free Cash Flow are Roche Holding AG, Novartis AG, Novo Nordisk A/S, AstraZeneca PLC, Sanofi, Bayer AG, GSK plc, MERCK Kommanditgesellschaft auf Aktien, Siemens Healthineers AG and Jazz Pharmaceuticals plc.

What are the bottom 10 Biotechnology companies in Europe by Free Cash Flow ?

The bottom 10 Biotechnology companies in Europe by Free Cash Flow are Clinical Laserthermia Systems AB (publ), Cizzle Biotechnology Holdings Plc, aXichem AB, BioArctic AB (publ), Aptahem AB (publ), BB Biotech AG, ABIONYX Pharma SA, 2cureX AB (publ), Akari Therapeutics, Plc and CombiGene AB (publ).